Acamprosate Completed Phase 3 Trials for Alcohol Dependence / Schizophrenic Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00463346Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism